BTAI vs DHR · rev $388.0K vs P/E 39, rev $6.26B
BioXcel Therapeutics Inc (BTAI) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US. It is led by Rainer M. Blair.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
BTAI currently screens at market cap $36.1M. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the BTAI and DHR stock pages for the full models.
Not investment advice.